1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Shaanxi Kanghui Pharmaceutical Co., Ltd.

Shaanxi Kanghui Pharmaceutical Co., Ltd.

603139.SS
Shaanxi Kanghui Pharmaceutical Co., Ltd.CN flagShanghai Stock Exchange
40.51
CNY
-1.05
- -
4.05BMarket Cap

Total Valuation

Shaanxi Kanghui Pharmaceutical Co., Ltd. carries a market capitalization of 4.05B, placing it among publicly traded companies globally. Its enterprise value stands at 2.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.05B
Enterprise Value2.69B

Share Statistics

Shaanxi Kanghui Pharmaceutical Co., Ltd. currently has 99.88M shares outstanding.

Shares Outstanding99.88M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 3.96, and the price-to-book ratio stands at 6.37.

PE RatioN/A
PS Ratio3.96
PB Ratio6.37
P/TBV Ratio2.92
P/FCF Ratio73.73
P/OCF RatioN/A

Enterprise Valuation

EV / Sales4.95
EV / EBITDAN/A
EV / EBITN/A
EV / FCF45.68

Financial Position

Shaanxi Kanghui Pharmaceutical Co., Ltd. maintains a current ratio of 0.96, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 73.14, indicating elevated leverage, while an interest coverage ratio of -2.09 demonstrates limited ability to service its debt obligations.

Current Ratio0.96
Quick Ratio0.18
Debt / Equity73.14
Debt / EBITDA-9.02
Interest Coverage-2.09

Financial Efficiency

Return on Equity (ROE)-30.43
Return on Assets (ROA)-6.20
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.84

Taxes

Income Tax-16.21M
Effective Tax RateN/A

Stock Price Statistics

Shaanxi Kanghui Pharmaceutical Co., Ltd.'s stock has gained approximately 75.06482% over the past 52 weeks. The 50-day moving average sits at 38.70, while the 200-day moving average is 27.54.

Beta (5Y)N/A
52-Week Price Change75.06482%
50-Day Moving Average38.70
200-Day Moving Average27.54
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Shaanxi Kanghui Pharmaceutical Co., Ltd. generated 543.50M in revenue and converted that into -121.13M in net income, yielding earnings per share of -1.50. EBITDA reached -68.86M, while operating income came in at -68.86M.

Revenue543.50M
Gross Profit151.59M
Operating Income-68.86M
Pretax Income-168.45M
Net Income-121.13M
EBITDA-68.86M
EBIT-68.86M
Earnings Per Share (EPS)-1.50

Balance Sheet

Shaanxi Kanghui Pharmaceutical Co., Ltd. holds 113.50M in cash and equivalents against 620.83M in total debt, resulting in a net debt position of 387.14M. Total book value stands at 337.43M, with working capital of -28.60M providing operational flexibility.

Cash & Cash Equivalents113.50M
Total Debt620.83M
Net Debt387.14M
Equity (Book Value)337.43M
Book Value Per Share3.33
Working Capital-28.60M

Cash Flow

After subtracting -29.16M in capital expenditures, free cash flow totaled -29.16M - equivalent to -0.29 per share.

Operating Cash FlowN/A
Capital Expenditures-29.16M
Free Cash Flow-29.16M
FCF Per Share-0.29

Margins

Shaanxi Kanghui Pharmaceutical Co., Ltd. operates with a gross margin of 27.89, reflecting its pricing power and cost economics. The operating margin of -12.67 and net profit margin of -22.29 provide insight into operational efficiency.

Gross Margin27.89
Operating Margin-12.67
Pretax Margin-30.99
Profit Margin-22.29
EBITDA Margin-12.67

Dividends & Yields

The company's payout ratio of -16.74 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.30
Dividend YieldN/A
Payout Ratio-16.74
Shareholder Yield3.42
FCF Yield1.36

Scores

Shaanxi Kanghui Pharmaceutical Co., Ltd. posts an Altman Z-Score of 1.62, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.62